Key result
Insulin resistance linked to greater CAD risk and severity, especially alongside T2D or metabolic syndrome.
Insulin resistance and its associated syndromes significantly increase the risk and severity of coronary artery disease, highlighting the importance of addressing metabolic risk factors.
May aid CAD risk stratification; leaves open whether targeting insulin resistance improves outcomes.
Insulin resistance and its associated conditions, type 2 diabetes mellitus and the metabolic syndrome, have assumed great public health significance in relation to the development of atherosclerotic coronary artery disease. While the overall incidence of coronary artery disease has been declining, its incidence has been increasing in populations with insulin resistance. When insulin resistance is present in conjunction with type 2 diabetes mellitus and/or the metabolic syndrome, as well as other risk factors, the chance of developing coronary artery disease is strikingly increased as are the frequency and severity of its complications. In these situations, insulin resistance may behave synergistically with other risk factors. In addition to clustering with conventional risk factors, more recent evidence indicates that insulin resistance is linked with 'non-traditional' coronary artery disease risk factors and possibly with a pro-atherosclerotic inflammatory state.
No takes yet. Share an insight, caveat, or question.
Martin M. LeWinter (2005) conducted a review in Coronary artery disease and insulin resistance. Insulin resistance was evaluated on Coronary artery disease. Insulin resistance, especially when combined with type 2 diabetes or metabolic syndrome, is strongly associated with an increased risk and severity of coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: